Crinetics Pharmaceuticals Stock Technical Analysis
| CRNX Stock | USD 46.86 0.61 1.29% |
As of the 29th of May, Crinetics Pharmaceuticals shows the Mean Deviation of 2.83, risk adjusted performance of 0.0731, and Downside Deviation of 2.62. Crinetics Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Crinetics Pharmaceuticals, which can be compared to its peers. Please confirm Crinetics Pharmaceuticals semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Crinetics Pharmaceuticals is priced correctly, providing market reflects its regular price of 46.86 per share. Given that Crinetics Pharmaceuticals has jensen alpha of 0.3715, we suggest you to validate Crinetics Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.
Crinetics Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Crinetics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CrineticsCrinetics |
Crinetics Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 46.89 | Strong Buy | 14 | Odds |
Most Crinetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Crinetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Crinetics Pharmaceuticals, talking to its executives and customers, or listening to Crinetics conference calls.
Crinetics Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Crinetics Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Crinetics Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Crinetics Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Crinetics Pharmaceuticals. You can use it to identify possible trend reversals for Crinetics Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Crinetics Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Crinetics Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Crinetics Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.12 , which means Crinetics Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 570.8, which is the sum of squared deviations for the predicted Crinetics Pharmaceuticals price change compared to its average price change.About Crinetics Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Crinetics Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Crinetics Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Crinetics Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Crinetics Pharmaceuticals. By analyzing Crinetics Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Crinetics Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Crinetics Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 21.55 | 12.45 | 13.07 | 17.96 | Net Debt To EBITDA | 1.83 | 0.18 | 0.0143 | 0.0136 |
Crinetics Pharmaceuticals May 29, 2024 Technical Indicators
Most technical analysis of Crinetics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Crinetics from various momentum indicators to cycle indicators. When you analyze Crinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0731 | |||
| Market Risk Adjusted Performance | 0.194 | |||
| Mean Deviation | 2.83 | |||
| Semi Deviation | 2.5 | |||
| Downside Deviation | 2.62 | |||
| Coefficient Of Variation | 909.41 | |||
| Standard Deviation | 4.0 | |||
| Variance | 16.0 | |||
| Information Ratio | 0.1012 | |||
| Jensen Alpha | 0.3715 | |||
| Total Risk Alpha | 0.2597 | |||
| Sortino Ratio | 0.1545 | |||
| Treynor Ratio | 0.184 | |||
| Maximum Drawdown | 26.28 | |||
| Value At Risk | (4.26) | |||
| Potential Upside | 5.66 | |||
| Downside Variance | 6.87 | |||
| Semi Variance | 6.23 | |||
| Expected Short fall | (3.78) | |||
| Skewness | 1.93 | |||
| Kurtosis | 7.06 |
Crinetics Pharmaceuticals May 29, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Crinetics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 29,892 | ||
| Daily Balance Of Power | (0.31) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 47.44 | ||
| Day Typical Price | 47.25 | ||
| Price Action Indicator | (0.89) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Crinetics Stock analysis
When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Crinetics Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Crinetics Pharmaceuticals. If investors know Crinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Crinetics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.72) | Revenue Per Share 0.032 | Quarterly Revenue Growth (0.76) | Return On Assets (0.24) | Return On Equity (0.41) |
The market value of Crinetics Pharmaceuticals is measured differently than its book value, which is the value of Crinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Crinetics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Crinetics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Crinetics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Crinetics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Crinetics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Crinetics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Crinetics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.